mu-Opioid receptor cell surface expression is regulated by its direct interaction with Ribophorin I

Xin Ge1, Horace H Loh, Ping-Yee Law

  • 1Department of Pharmacology, University of Minnesota Medical School, Minneapolis, 55455, USA. gexx0019@umn.edu

Molecular Pharmacology
|March 18, 2009
PubMed

Insights

Ribophorin I (RPNI) directly interacts with the mu-opioid receptor (MOR), a G protein-coupled receptor. This interaction regulates MOR trafficking, depending on the receptor's N-glycosylation status.

Area of Science:

  • Molecular biology
  • Cellular biology
  • Neuroscience

Background:

  • The mu-opioid receptor (MOR), a rhodopsin G protein-coupled receptor (GPCR), is crucial for pain modulation.
  • MOR trafficking is a complex process influenced by interactions with various cellular proteins.

Purpose of the Study:

  • To identify novel proteins that regulate MOR trafficking.
  • To elucidate the mechanism by which Ribophorin I (RPNI) influences MOR cell surface expression.

Main Methods:

  • Targeted proteomics and mass spectrometry to identify interacting proteins.
  • Small interfering RNA (siRNA) knockdown and overexpression studies.
  • Analysis of MOR trafficking in cells with altered RPNI levels and receptor glycosylation mutants.

Main Results:

  • RPNI was identified as a direct interacting partner of MOR.
  • siRNA-mediated knockdown of RPNI resulted in intracellular retention of MOR.
  • Overexpression of RPNI rescued surface expression of a MOR mutant, independent of calnexin.
  • RPNI's effect on MOR trafficking is dependent on the N-glycosylation status of the receptor.

Conclusions:

  • RPNI acts as a novel chaperone, regulating MOR trafficking through N-glycosylation-dependent interactions.
  • This finding reveals a new mechanism controlling GPCR trafficking and function.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...